New Orleans, United States
Bioceptive, founded in 2010, is a pioneering company in the Biotechnology and Medical Devices sector, focusing specifically on Women's Health. Their mission aligns with enhancing global well-being by improving women's health procedures, guided by a commitment to innovation and patient-centric design.
Their breakthrough product is a cervical retraction device using gentle suction as an alternative to the traditional, painful tenaculum used in gynecological procedures. This innovation reflects Bioceptive's dedication to providing less traumatic options for women.
Currently, they are developing a second innovation—a simplified IUD insertion device—supported by multiple grants, including the Saving Lives at Birth consortium of the Gates Foundation and USAID. This endeavor underlines their focus on empowering women globally with safe family planning options.
Bioceptive last secured a $416.45K Venture Round investment on 08 February 2016 from the New Orleans Biofund, highlighting sustained investor interest in their mission-driven advances.
